Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Survival outcomes in metastatic prostate cancer in the population Brazilian - analysis of individual characteristics and modalities of treatment in different national health institutions
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Public institution | Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017 | ||
| Private institution | Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017 |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Describe cause-specific survival in patients with castration-resistant prostate cancer in different institutions in Brazil. | December of 2017 |
| Measure | Description | Time Frame |
|---|---|---|
| To describe the sociodemographic characteristics of patients with castration-resistant metastatic prostate cancer in Brazil; | December of 2017 | |
| To describe comorbidities of patients with castration-resistant metastatic prostate cancer in Brazil; | December of 2017 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Diagnosis of castration-resistant metastatic prostate cancer diagnosed in the period between January 2014 and December 2017.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Fernando Cotait Maluf | Latin American Cooperative Oncology Group | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CPO Pucrs | Porto Alegre | Rio Grande do Sul | Brazil | |||
| Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| To describe the clinicopathological characteristics of patients with metastatic castration-resistant prostate cancer in Brazil; | December of 2017 |
| To compare overall survival among patients with castration-resistant metastatic prostate cancer treated in the SUS and in the private network; | December of 2017 |
| To compare the treatments performed by patients with castration-resistant metastatic prostate cancer in the SUS and in the private network; | December of 2017 |
| To describe the rates of skeletal-related complications | December of 2017 |
| To describe the rate of admissions | December of 2017 |
| To describe the number of lines of treatment that patients have undergone | December of 2017 |
| To describe the presence or absence of treatments bone-directed | December of 2017 |
| Santo André |
| São Paulo |
| 09060-650 |
| Brazil |
| Sírio Libanês | São Paulo | São Paulo | 01308-050 | Brazil |
| Centro Paulista de Oncologia | São Paulo | São Paulo | Brazil |
| Hospital Santa Marcelina | São Paulo | (11) 2070-6000 | Brazil |
| BP - A Beneficência Portuguesa de São Paulo | São Paulo | 01.323-030 | Brazil |
| Irmandade da Santa Casa de Misericórdia de São Paulo - Hospital Central | São Paulo | 01221-010 | Brazil |
| A.C.Camargo Cancer Center | São Paulo | 01525-001 | Brazil |
| ID | Term |
|---|---|
| D064129 | Prostatic Neoplasms, Castration-Resistant |
| D011471 | Prostatic Neoplasms |
| ID | Term |
|---|---|
| D005834 | Genital Neoplasms, Male |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D005832 | Genital Diseases, Male |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D011469 | Prostatic Diseases |
| D052801 | Male Urogenital Diseases |
Not provided
Not provided